Frank Ruffo
2020
In 2020, Frank Ruffo earned a total compensation of $811.6K as Chief Financial Officer at Aclaris Therapeutics, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $179,400 |
|---|---|
| Option Awards | $105,356 |
| Salary | $390,000 |
| Stock Awards | $125,453 |
| Other | $11,400 |
| Total | $811,609 |
Ruffo received $390K in salary, accounting for 48% of the total pay in 2020.
Ruffo also received $179.4K in non-equity incentive plan, $105.4K in option awards, $125.5K in stock awards and $11.4K in other compensation.
Rankings
In 2020, Frank Ruffo's compensation ranked 9,443rd out of 13,090 executives tracked by ExecPay. In other words, Ruffo earned more than 27.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,443 out of 13,090 | 28th |
Division Manufacturing | 4,044 out of 5,624 | 28th |
Major group Chemicals And Allied Products | 1,643 out of 2,257 | 27th |
Industry group Drugs | 1,439 out of 1,957 | 27th |
Industry Pharmaceutical Preparations | 1,056 out of 1,462 | 28th |
Source: SEC filing on April 21, 2022.
Ruffo's colleagues
We found three more compensation records of executives who worked with Frank Ruffo at Aclaris Therapeutics in 2020.